BOTOX 200 UNITÉS ALLERGAN

DRUG2 trials

Sponsors

Ipsen Pharma, Centre Hospitalier Universitaire Rouen

Conditions

Fecal incontinenceUpper limb spasticity (ULS) of any aetiology (in US and France) or post- stroke ULS (in Canada)

Phase 3

Mechanisms of action on rectal motility of intrarectal botulinum toxin injections in patients with fecal incontinence - MECA-TOX

RecruitingCTIS2024-515256-21-00

Centre Hospitalier Universitaire RouenFecal incontinence

Start: 2025-03-21Target: 21Updated: 2025-06-02

Phase 4

A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison with OnabotulinumtoxinA (Botox®) when Treating Adults with Upper Limb Spasticity

CompletedCTIS2023-509196-16-00

Ipsen PharmaUpper limb spasticity (ULS) of any aetiology (in US and France) or post- stroke ULS (in Canada)

Start: 2021-11-19End: 2025-03-04Target: 50Updated: 2026-01-12